Notice: This company has been marked as potentially delisted and may not be actively trading. Selecta Biosciences (SELB) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Leigh Francis insists Bo Selecta! reboot will never happenOctober 20, 2024 | msn.comLeigh Francis in Leeds: Keith Lemon and Bo Selecta! star announces evening of laughter at Leeds Grand TheatreSeptember 23, 2024 | msn.comLeigh Francis interview: Leeds comedian of Keith Lemon and Bo' Selecta! fame on his fear of being cancelledSeptember 20, 2024 | msn.comCraig David says Leigh Francis' Bo Selecta! skit 'sent him down a dark road'May 6, 2024 | msn.comSelb, Germany - Weather Forecasts | Maps | News - Yahoo WeatherJanuary 23, 2024 | yahoo.comCartesian Therapeutics Inc (RNAC)December 15, 2023 | investing.comFurther weakness as Selecta Biosciences (NASDAQ:SELB) drops 17% this week, taking five-year losses to 85%November 14, 2023 | finance.yahoo.comPared-down Selecta merges with Maryland biotechNovember 13, 2023 | bizjournals.comSelecta Biosciences Merges With Cartesian To Focus On Autoimmune Cell TherapyNovember 13, 2023 | msn.comSelecta Biosciences Merges With Cartesian Therapeutics In All-stock DealNovember 13, 2023 | markets.businessinsider.comTrading was temporarily halted for "SELB" at 08:11 AM with a stated reason of "News pending."November 13, 2023 | marketbeat.comSHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Selecta Biosciences, Inc. (NASDAQ: SELB) and Encourages Investors to Contact the FirmNovember 11, 2023 | benzinga.comSelecta Biosciences Inc SELBNovember 10, 2023 | morningstar.comSelecta Biosciences in Deal to Transfer Manufacturing, Development Rights of Sel-212 TreatmentOctober 31, 2023 | marketwatch.comSelecta Announces Transition of Manufacturing and Clinical Operations of ImmTOR for SEL-212 to Commercialization Partner SobiOctober 31, 2023 | finance.yahoo.comSelecta Biosciences files for $200M mixed shelfOctober 25, 2023 | msn.comMizuho Maintains Selecta Biosciences (SELB) Buy RecommendationAugust 19, 2023 | msn.comSVB Leerink Downgrades Selecta Biosciences (SELB)August 19, 2023 | msn.comAnalyst Ratings for Selecta BiosciencesAugust 18, 2023 | markets.businessinsider.comNeedham Maintains Selecta Biosciences (SELB) Buy RecommendationAugust 18, 2023 | msn.comSelecta Biosciences (SELB) Gets a Buy from H.C. WainwrightAugust 18, 2023 | markets.businessinsider.comSelecta Biosciences (NASDAQ:SELB) Releases Quarterly Earnings Results, Beats Estimates By $0.05 EPSSelecta Biosciences (NASDAQ:SELB - Get Free Report) announced its earnings results on Thursday. The company reported ($0.07) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.12) by $0.05. Selecta Biosciences had a negative net margin of 18.21% and a negative return on equity of 17.67%. The company had revenue of $5.25 million for the quarter, compared to analysts' expectations of $9.90 million.August 18, 2023 | marketbeat.comSelecta Biosciences' (SELB) "Market Perform" Rating Reaffirmed at SVB LeerinkSVB Leerink reaffirmed a "market perform" rating and issued a $1.00 price target on shares of Selecta Biosciences in a report on Friday.August 18, 2023 | marketbeat.comMizuho Securities Reaffirms Their Buy Rating on Selecta Biosciences (SELB)August 17, 2023 | markets.businessinsider.comQ2 2023 Selecta Biosciences Inc Earnings CallAugust 17, 2023 | finance.yahoo.comSelecta Biosciences Narrows R&D Focus On Gout CandidateAugust 17, 2023 | msn.comSelecta Biosciences, Inc. (SELB) Reports Q2 Loss, Misses Revenue EstimatesAugust 17, 2023 | finance.yahoo.comSelecta Biosciences Reports Second Quarter 2023 Financial Results and Updates on Strategic Initiative Designed to Maximize Stockholder Value Associated with SEL-212 EconomicsAugust 17, 2023 | finance.yahoo.comSelecta Biosciences, Inc.'s (NASDAQ:SELB) largest shareholders are individual investors with 35% ownership, institutions own 26%July 14, 2023 | finance.yahoo.comSelecta Biosciences (NASDAQ:SELB) Rating Lowered to Hold at StockNews.comStockNews.com cut Selecta Biosciences from a "buy" rating to a "hold" rating in a report on Friday.June 9, 2023 | marketbeat.comSelecta Biosciences, Inc. (NASDAQ:SELB) Shares Sold by GSA Capital Partners LLPGSA Capital Partners LLP cut its holdings in shares of Selecta Biosciences, Inc. (NASDAQ:SELB - Get Rating) by 48.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 372,087 shares of theJune 8, 2023 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Sells 119,611 Shares of Selecta Biosciences, Inc. (NASDAQ:SELB)Connor Clark & Lunn Investment Management Ltd. decreased its holdings in shares of Selecta Biosciences, Inc. (NASDAQ:SELB - Get Rating) by 81.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 27,239 shJune 6, 2023 | marketbeat.comSelecta Biosciences (NASDAQ:SELB) shareholders are up 22% this past week, but still in the red over the last five yearsJune 3, 2023 | finance.yahoo.comSelecta Biosciences Announces Presentation of Data from Phase 3 DISSOLVE Program of SEL-212 in Chronic Refractory Gout During Late-Breaking Session at the EULAR 2023 European Congress of RheumatologyMay 31, 2023 | finance.yahoo.comSelecta Biosciences, Inc. (NASDAQ:SELB) Receives Consensus Rating of "Moderate Buy" from BrokeragesSelecta Biosciences, Inc. (NASDAQ:SELB - Get Rating) has been given a consensus recommendation of "Moderate Buy" by the seven brokerages that are presently covering the company, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation and five have given a buy recommendatMay 12, 2023 | marketbeat.comNewsflash: Selecta Biosciences, Inc. (NASDAQ:SELB) Analysts Have Been Trimming Their Revenue ForecastsMay 9, 2023 | finance.yahoo.comHC Wainwright & Co. Reiterates Selecta Biosciences (SELB) Buy RecommendationMay 8, 2023 | msn.comStockNews.com Downgrades Selecta Biosciences (NASDAQ:SELB) to HoldStockNews.com cut Selecta Biosciences from a "buy" rating to a "hold" rating in a research note on Friday.May 5, 2023 | marketbeat.comSelecta cuts in-house gene therapy programs, lays off 15May 5, 2023 | bizjournals.comMizuho Securities Sticks to Their Buy Rating for Selecta Biosciences (SELB)May 4, 2023 | markets.businessinsider.comSelecta Biosciences, Inc. (SELB) Reports Q1 Loss, Misses Revenue EstimatesMay 4, 2023 | finance.yahoo.comSelecta Biosciences, Inc.: Selecta Biosciences Reports First Quarter 2023 Financial Results and Provides Business UpdateMay 4, 2023 | finanznachrichten.deSelecta Biosciences Reports First Quarter 2023 Financial Results and Provides Business UpdateMay 4, 2023 | finance.yahoo.comSelecta Biosciences to Host Conference Call and Webcast to Discuss First Quarter 2023 Financial Results and Provide Business UpdateApril 28, 2023 | finance.yahoo.comInvestors Holding Back On Selecta Biosciences, Inc. (NASDAQ:SELB)April 18, 2023 | finance.yahoo.comNeedham Reiterates Selecta Biosciences (SELB) Buy RecommendationApril 13, 2023 | msn.comWhat 6 Analyst Ratings Have To Say About Selecta BiosciencesApril 13, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: United Therapeutics (UTHR), Selecta Biosciences (SELB) and Denali Therapeutics (DNLI)April 13, 2023 | markets.businessinsider.comIs Selecta Biosciences, Inc.'s (NASDAQ:SELB) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?March 27, 2023 | finance.yahoo.comThe Latest Analyst Ratings for Selecta BiosciencesMarch 22, 2023 | markets.businessinsider.com Get Selecta Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SELB and its competitors with MarketBeat's FREE daily newsletter. Email Address JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback. Get your free guide NOW before it's too late. SELB Media Mentions By Week SELB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SELB News Sentiment▼0.000.50▲Average Medical News Sentiment SELB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SELB Articles This Week▼00▲SELB Articles Average Week Get Selecta Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SELB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CytomX Therapeutics News Today LianBio News Today PHAXIAM Therapeutics News Today Alpha Tau Medical News Today BriaCell Therapeutics News Today eFFECTOR Therapeutics News Today Fortress Biotech News Today GeoVax Labs News Today Sanofi News Today Pfizer News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SELB) was last updated on 11/24/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Porter & Company | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | Sponsored#1 Crypto of 2024Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Selecta Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Selecta Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
